Brain Advance Access originally published online on March 23, 2005
Brain 2005 128(6):1247-1258; doi:10.1093/brain/awh488
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
1 The Queen Square Brain Bank for Neurological Disorders, 2 Reta Lila Weston Institute for Neurological Studies and 3 Institute of Neurology, University College London, 4 Sara Koe PSP Research Centre and 5 Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK
Correspondence to: Professor Andrew J. Lees, Reta Lila Weston Institute for Neurological Studies, 46 Cleveland St, London W1T 4JF, UK E-mail: alees{at}ion.ucl.ac.uk
The clinical diagnosis of progressive supranuclear palsy (PSP) relies on the identification of characteristic signs and symptoms. A proportion of pathologically diagnosed cases do not develop these classic features, prove difficult to diagnose during life and are considered as atypical PSP. The aim of this study was to examine the apparent clinical dichotomy between typical and atypical PSP, and to compare the biochemical and genetic characteristics of these groups. In 103 consecutive cases of pathologically confirmed PSP, we have identified two clinical phenotypes by factor analysis which we have named Richardson's syndrome (RS) and PSP-parkinsonism (PSP-P). Cases of RS syndrome made up 54% of all cases, and were characterized by the early onset of postural instability and falls, supranuclear vertical gaze palsy and cognitive dysfunction. A second group of 33 (32%) were characterized by asymmetric onset, tremor, a moderate initial therapeutic response to levodopa and were frequently confused with Parkinson's disease (PSP-P). Fourteen cases (14%) could not be separated according to these criteria. In RS, two-thirds of cases were men, whereas the sex distribution in PSP-P was even. Disease duration in RS was significantly shorter (5.9 versus 9.1 years, P < 0.001) and age at death earlier (72.1 versus 75.5 years, P = 0.01) than in PSP-P. The isoform composition of insoluble tangle-tau isolated from the basal pons also differed significantly. In RS, the mean four-repeat:three-repeat tau ratio was 2.84 and in PSP-P it was 1.63 (P < 0.003). The effect of the H1,H1 PSP susceptibility genotype appeared stronger in RS than in PSP-P (odds ratio 13.2 versus 4.5). The difference in genotype frequencies between the clinical subgroups was not significant. There were no differences in apolipoprotein E genotypes. The classic clinical description of PSP, which includes supranuclear gaze palsy, early falls and dementia, does not adequately describe one-third of cases in this series of pathologically confirmed cases. We propose that PSP-P represents a second discrete clinical phenotype that needs to be clinically distinguished from classical PSP (RS). The different tau isoform deposition in the basal pons suggests that this may ultimately prove to be a discrete nosological entity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Bensimon, A. Ludolph, Y. Agid, M. Vidailhet, C. Payan, P. N. Leigh, and for the NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study Brain, January 1, 2009; 132(1): 156 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Golbe Early diagnosis of progressive supranuclear palsy: Bucking the odds Neurology, November 25, 2008; 71(22): 1754 - 1755. [Full Text] [PDF]
|
|
|
|
|
|
B. Borroni, M. Malinverno, F. Gardoni, A. Alberici, L. Parnetti, E. Premi, U. Bonuccelli, M. Grassi, D. Perani, P. Calabresi, et al. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy Neurology, November 25, 2008; 71(22): 1796 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Caslake, J N Moore, J C Gordon, C E Harris, and C Counsell Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1202 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rizzo, P. Martinelli, D. Manners, C. Scaglione, C. Tonon, P. Cortelli, E. Malucelli, S. Capellari, C. Testa, P. Parchi, et al. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease Brain, October 1, 2008; 131(10): 2690 - 2700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Apartis, B. Gaymard, S. Verhaeghe, E. Roze, M. Vidailhet, and A. Lannuzel Predominant cortical dysfunction in Guadeloupean parkinsonism Brain, October 1, 2008; 131(10): 2701 - 2709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, and A. J. Lees Clinical outcomes of progressive supranuclear palsy and multiple system atrophy Brain, May 1, 2008; 131(5): 1362 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Williams, A. J. Lees, J. R. Wherrett, and J. C. Steele J. Clifford Richardson and 50 years of progressive supranuclear palsy Neurology, February 12, 2008; 70(7): 566 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Ahmed, K. A. Josephs, J. Gonzalez, A. DelleDonne, and D. W. Dickson Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy Brain, February 1, 2008; 131(2): 460 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Quattrone, G. Nicoletti, D. Messina, F. Fera, F. Condino, P. Pugliese, P. Lanza, P. Barone, L. Morgante, M. Zappia, et al. MR Imaging Index for Differentiation of Progressive Supranuclear Palsy from Parkinson Disease and the Parkinson Variant of Multiple System Atrophy Radiology, December 1, 2007; 246(1): 214 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Kaat, A.J.W. Boon, W. Kamphorst, R. Ravid, H. J. Duivenvoorden, and J. C. van Swieten Frontal presentation in progressive supranuclear palsy Neurology, August 21, 2007; 69(8): 723 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Williams, J. L. Holton, C. Strand, A. Pittman, R. de Silva, A. J. Lees, and T. Revesz Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome Brain, June 1, 2007; 130(6): 1566 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I. Golbe and P. A. Ohman-Strickland A clinical rating scale for progressive supranuclear palsy Brain, June 1, 2007; 130(6): 1552 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lannuzel, G. U. Hoglinger, S. Verhaeghe, L. Gire, S. Belson, M. Escobar-Khondiker, P. Poullain, W. H. Oertel, E. C. Hirsch, B. Dubois, et al. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain, March 1, 2007; 130(3): 816 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schrag, C. Selai, N. Quinn, A. Lees, I. Litvan, A. Lang, Y. Poon, J. Bower, D. Burn, and J. Hobart Measuring quality of life in PSP: The PSP-QoL. Neurology, July 11, 2006; 67(1): 39 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S M Taylor and C. Counsell Is it Parkinson's disease, and if not, what is it? Practical Neurology, June 1, 2006; 6(3): 154 - 165. [Full Text] [PDF]
|
|
|
|
|
|
K. A. Josephs, J. R. Duffy, E. A. Strand, J. L. Whitwell, K. F. Layton, J. E. Parisi, M. F. Hauser, R. J. Witte, B. F. Boeve, D. S. Knopman, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech Brain, June 1, 2006; 129(6): 1385 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D R Williams, H C Watt, and A J Lees Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 468 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Paviour, S. L. Price, M. Jahanshahi, A. J. Lees, and N. C. Fox Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy Brain, April 1, 2006; 129(4): 1040 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Factor, D. S. Higgins, and J. Qian Primary progressive freezing gait: A syndrome with many causes Neurology, February 14, 2006; 66(3): 411 - 414. [Abstract] [Full Text] [PDF]
|
|